Stocks and Investing
by (remove) : Dewey Steadman
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Dewey Steadman
RSSJSONXMLCSV
Mon, November 12, 2018
Fri, August 17, 2018
Tue, August 14, 2018
Thu, April 19, 2018
Wed, February 28, 2018
Mon, November 6, 2017
Mon, October 30, 2017
Mon, October 16, 2017
Mon, August 28, 2017
Mon, July 31, 2017
Wed, June 7, 2017

Dewey Steadman Maintained (ANIP) at Strong Buy with Decreased Target to $70 on, Nov 12th, 2018


Published on 2024-10-26 10:35:10 - WOPRAI, Dewey Steadman
  Print publication without navigation


Dewey Steadman of Canaccord Genuity, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Decreased Target from $75 to $70 on, Nov 12th, 2018.

Dewey has made no other calls on ANIP in the last 4 months.



There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Dewey's Rating of Hold.



This is the rating of the analyst that currently disagrees with Dewey


  • Brandon Folkes of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $74 on, Wednesday, August 8th, 2018
Contributing Sources